StonvexLoading…
StonvexCore line items from WMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.72B | $14.90B | $11.06B | $7.57B |
Operating Income | $1.32B | $4.20B | $3.15B | $2.04B |
Net Income | $865.00M | $2.62B | $1.88B | $1.24B |
EPS (Diluted) | $0.70 | $2.14 | $1.54 | $1.01 |
Total Assets | $59.57B | $58.57B | $55.74B | $56.14B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $950.00M | $63.00M | $70.00M | $903.00M |
Free Cash Flow OCF − CapEx | $244.00M | $1.00B | $1.38B | $899.00M |
Shares Outstanding | 1.23B | 1.23B | 1.22B | 1.22B |